Lotus Pharmaceutical Statistics
Total Valuation
TPE:1795 has a market cap or net worth of TWD 54.80 billion. The enterprise value is 94.53 billion.
| Market Cap | 54.80B |
| Enterprise Value | 94.53B |
Important Dates
The next estimated earnings date is Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | Aug 11, 2025 |
Share Statistics
TPE:1795 has 262.81 million shares outstanding. The number of shares has decreased by -0.67% in one year.
| Current Share Class | 262.81M |
| Shares Outstanding | 262.81M |
| Shares Change (YoY) | -0.67% |
| Shares Change (QoQ) | +0.84% |
| Owned by Insiders (%) | 0.80% |
| Owned by Institutions (%) | 10.51% |
| Float | 161.51M |
Valuation Ratios
The trailing PE ratio is 11.56 and the forward PE ratio is 12.39.
| PE Ratio | 11.56 |
| Forward PE | 12.39 |
| PS Ratio | 2.67 |
| PB Ratio | 2.30 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 8.89 |
| P/OCF Ratio | 7.32 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.22, with an EV/FCF ratio of 15.34.
| EV / Earnings | 20.03 |
| EV / Sales | 4.61 |
| EV / EBITDA | 12.22 |
| EV / EBIT | 15.23 |
| EV / FCF | 15.34 |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 2.00.
| Current Ratio | 1.57 |
| Quick Ratio | 0.92 |
| Debt / Equity | 2.00 |
| Debt / EBITDA | 6.14 |
| Debt / FCF | 7.70 |
| Interest Coverage | 7.07 |
Financial Efficiency
Return on equity (ROE) is 21.00% and return on invested capital (ROIC) is 11.09%.
| Return on Equity (ROE) | 21.00% |
| Return on Assets (ROA) | 5.30% |
| Return on Invested Capital (ROIC) | 11.09% |
| Return on Capital Employed (ROCE) | 6.95% |
| Weighted Average Cost of Capital (WACC) | 3.80% |
| Revenue Per Employee | 18.66M |
| Profits Per Employee | 4.29M |
| Employee Count | 1,099 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 1.28 |
Taxes
In the past 12 months, TPE:1795 has paid 998.12 million in taxes.
| Income Tax | 998.12M |
| Effective Tax Rate | 17.46% |
Stock Price Statistics
The stock price has decreased by -17.26% in the last 52 weeks. The beta is 0.28, so TPE:1795's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -17.26% |
| 50-Day Moving Average | 288.67 |
| 200-Day Moving Average | 255.19 |
| Relative Strength Index (RSI) | 31.27 |
| Average Volume (20 Days) | 4,663,872 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:1795 had revenue of TWD 20.51 billion and earned 4.72 billion in profits. Earnings per share was 18.04.
| Revenue | 20.51B |
| Gross Profit | 11.91B |
| Operating Income | 6.21B |
| Pretax Income | 5.72B |
| Net Income | 4.72B |
| EBITDA | 7.61B |
| EBIT | 6.21B |
| Earnings Per Share (EPS) | 18.04 |
Balance Sheet
The company has 7.74 billion in cash and 47.48 billion in debt, with a net cash position of -39.74 billion or -151.20 per share.
| Cash & Cash Equivalents | 7.74B |
| Total Debt | 47.48B |
| Net Cash | -39.74B |
| Net Cash Per Share | -151.20 |
| Equity (Book Value) | 23.78B |
| Book Value Per Share | 90.48 |
| Working Capital | 9.57B |
Cash Flow
In the last 12 months, operating cash flow was 7.48 billion and capital expenditures -1.32 billion, giving a free cash flow of 6.16 billion.
| Operating Cash Flow | 7.48B |
| Capital Expenditures | -1.32B |
| Depreciation & Amortization | 1.40B |
| Net Borrowing | 9.19B |
| Free Cash Flow | 6.16B |
| FCF Per Share | 23.45 |
Margins
Gross margin is 58.05%, with operating and profit margins of 30.26% and 23.01%.
| Gross Margin | 58.05% |
| Operating Margin | 30.26% |
| Pretax Margin | 27.88% |
| Profit Margin | 23.01% |
| EBITDA Margin | 37.10% |
| EBIT Margin | 30.26% |
| FCF Margin | 30.05% |
Dividends & Yields
This stock pays an annual dividend of 2.56, which amounts to a dividend yield of 1.21%.
| Dividend Per Share | 2.56 |
| Dividend Yield | 1.21% |
| Dividend Growth (YoY) | 24.34% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 32.20% |
| Buyback Yield | 0.67% |
| Shareholder Yield | 1.93% |
| Earnings Yield | 8.61% |
| FCF Yield | 11.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPE:1795 has an Altman Z-Score of 1.17 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.17 |
| Piotroski F-Score | 4 |